Search Intelligence

“When a biotech loses its mega-cap pharma lifeline, aggressive cash conservation through mass layoffs is just the first step in delaying the inevitable.”

“When Medicare starts footing the bill for weight loss drugs, the pharma company that secures the first-mover advantage essentially locks in a permanent pipeline of taxpayer cash.”

“Landing $2.6B in a capital-starved European market isn't just a fundraising win, it gives Forbion a near-monopoly on dictating term sheets to desperate founders.”